Table 2.
Rank | Drug | Condition (Reference) | Classification/Use |
---|---|---|---|
1 | Arotinoid acid | Arotinoid | |
2 | Folic acid | Asthma* (7) | Vitamin |
3 | Levodopa | Dopamine agonist | |
4 | Acebutolol | Beta adrenergic receptor blocker | |
5 | Alvespimycin | HSP90 inhibitor | |
6 | Isoxsuprine | Asthma (mixed) (11, 93) | Beta adrenergic receptor agonist |
7 | PHA-00851261E | Unknown | |
8 | Sulfabenzamide | Antibiotic | |
9 | Cefaclor | Antibiotic | |
10 | Iproniazid | Bronchoconstriction (5) | Antidepressant |
11 | Amitriptyline | Bronchoconstriction (2) | Antidepressant |
12 | Pioglitazone | Asthma (55) | PPAR agonist |
13 | Fluorocurarine | Sympathetic ganglion blocker | |
14 | Piperacillin | Bronchoconstriction* (52) | Antibiotic |
15 | Tanespimycin | HSP90 inhibitor | |
16 | Dyclonine | Local anesthetic | |
17 | Naftifine | Antifungal | |
18 | Alpha ergocryptine | Alkaloid | |
19 | Paroxetine | Antidepressant | |
20 | Josamycin | Antibiotic | |
21 | Mecamylamine | Bronchoconstriction (28) | Cholinergic antagonist |
22 | Etanidazole | Decreases glutathione | |
23 | Digoxigenin | Steroid | |
24 | Medrysone | Corticosteroid | |
25 | PF-00539745-00 | Unknown |
Rank is order of correlation. CMAP, connectivity map; HSP, heat shock protein; PPAR, peroxisome proliferator-activated receptor.
Adverse effect.